Celgene seeks new EMA uses for Revlimid; Italy adds Pfizer, Merck meds to mandatory list;

@FiercePharma: GSK whistleblower details Cidra plant woes. News |  Follow @FiercePharma

> Celgene has asked European regulators to approve new uses of its blood cancer drugs Revlimid and Istodax. Celgene release | Item

> Italy's medicines agency has published the list of innovative medicines that must be supplied by its regions and provinces; it includes such drugs as Merck's HIV treatment Isentress and Pfizer's macular degeneration treatment Macugen. Story

> Momenta Pharmaceuticals hired Biogen Idec business development officer Young T. Kwon to fill a new post as vice president of business development. Momenta release | Article

> The U.S. Pharmacopeial Convention, which sets drug standards, proposed changes to drug labels designed to make them easier for patients to understand. Report

> Pfizer has asked a court to delay Dr Reddy's Laboratories' planned launch of a low-cost version of Lipitor (atorvastatin) in the U.S. Item

> Otsuka Holdings failed to sell an extra allotment of shares to investors after a $2 billion-plus IPO due to its sluggish stock performance, in a sign of ongoing weak demand in Japan for newly debuted shares. Story

> More than 2 million Medicare beneficiaries have failed to sign up for a subsidy program that could save them thousands of dollars a year in drug costs despite government mailings, ads and even pitches from rock and roll legend Chubby Checker. News

Biotech News

@FierceBiotech: Inspire shares tank after lead CF drug fails Ph3. Story | Follow @FierceBiotech

@JohnCFierce: New drug approvals are low. Favre says he will retire. Some things never change. Follow @JohnCFierce

> Xoma snags $505 million pact on its top drug prospect. News 

> Novartis R&D strategy keeps marketers on the sidelines. Article 

> Pfizer ups ante on Santaris RNA discovery deal with $614M pact. Story

> Newly-hatched PanOptica lands $30M A round for eye drugs. Report

Biotech Research News

> Colonoscopies more effective in hands of competent physicians. Story 

> Veridex, Mass. General work on test for circulating tumor cells. Item 

> Criminals can expect bad-hair days with DNA color tracking. Article 

> CF protein also a culprit in emphysema. Report 

> Researchers set sights on glaucoma vision loss. News 

> Japanese researchers to try stem cell breast regeneration. Report 

Manufacturing News

> Particles contaminate American Regent injectables. News

> DPT shot spoiled in India's ongoing vax saga. Article

> Caraco's Detroit plant rehab timeline extended. Story

> Asian API makers run afoul of EU regulator. News

> Synbiotics gets no-confidence warning from FDA. Article

> Glucose test strip age may be behind Abbott recall. Story

And Finally... Researchers have found new evidence that our genes help determine our susceptibility to depression. Report